Memory technology company 4DS Memory has wrapped up its first day of trading on the ASX, closing well below its opening price but above the price of its recent capital raising.
Local biotech firm Sun Biomedical has announced plans to buy Melbourne-based Dimerix Bioscience in exchange for a share package worth about $8.3 million.
Blue chip mineral sands miner Iluka Resources and small biotech Sun Biomedical are as different as chalk and cheese; but what they share, apart from a Perth base, is a willingness to invest in Western Australia's emerging technology ‘accelerator' programs.
Chairman Howard Digby has moved from a non-executive to an executive role at Sun Biomedical.Mr Digby has been the non-executive chairman of the company since January 2013.
